Navigation Links
Mithridion wins grants for Alzheimer's research

Madison, Wis. - Mithridion, Inc., a biopharmaceutical startup that is developing drugs to disrupt the progress of Alzheimer's disease, has secured $296,800 in federal grants to evaluate tests for drug candidates.

The twin grants, awarded by the National Institute on Aging, a branch of th......

Full article >>> the brain that might shield neurons from Amyloid beta, the primary toxin in Alzheimers.

"The advantage of small molecules is that they can be synthesized by chemical means, they can be accurately analyzed, they are relatively low cost for production, and they have a very well-trodden path for getting Food and Drug Administration approval," Twose sa......

Full article >>> > "That's a major advantage and it really stimulates innovation," Twose said. "These grants are really the lifeblood of many, many biotech companies."

......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/29/06


Related biology technology :

1. Mithridion raises $1.6M through angel networks
2. Digital Healthcare Conference, Mithridion, lack of degrees
3. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
4. State to offer $850K in high-tech training grants
5. Venture-backed firms could become eligible for federal SBIR grants
6. NASDAQ grants Merge more time for compliance
7. Morgridge seed grants attract over 220 proposals
8. Medical College researchers win federal grants
9. NSF grants bolster integrative graduate study at UW-Madison
10. Three state businesses receive technology grants
11. Visonex plans to expand with state grants, loan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):